Hence, monitoring NT-proBNP levels may assist in identifying individuals at high risk of adverse cardiovascular events such as left ventricular systolic dysfunction, left ventricular hypertrophy, and heart failure [6–8]. This evidence concerns the gene NPPB and left ventricular hypertrophy.